LncRNA C5orf66-AS1、LncRNA SOX2-OT在乳腺癌组织中的表达水平及与临床病理特征和预后的关系OA
Expression of LncRNA C5orf66-AS1 and LncRNA SOX2-OT in breast cancer tissues and their relationship with clinicopathological features and prognosis
目的 分析长链非编码RNA(LncRNA)C5orf66-AS1、LncRNA SOX2-OT在乳腺癌组织中的表达水平及与临床病理特征和预后的关系.方法 选取2020年8月至2022年4月在该院行改良根治术的107例乳腺癌患者为研究对象,收集术中切除的乳腺癌组织和癌旁组织标本.RT-qPCR检测LncRNA C5orf66-AS1、LncRNA SOX2-OT在癌组织及癌旁组织中的表达水平,分析 LncRNA C5orf66-AS1、LncRNA SOX2-OT表达水平与患者病理特征的关系,Kaplan-Meier法分析LncRNA C5orf66-AS1、LncRNA SOX2-OT表达水平与患者术后生存率的关系,单因素及多因素 Cox回归分析乳腺癌患者术后3年死亡的影响因素.结果 相较于癌旁组织,乳腺癌组织中 LncRNA C5orf66-AS1及 LncRNA SOX2-OT 表达水平升高(P<0.05).乳腺癌组织中LncRNA C5orf66-AS1及LncRNA SOX2-OT表达水平与患者TNM 分期、分化程度及有无淋巴结 转 移 有 关(P<0.05).乳腺癌组织中 LncRNA C5orf66-AS1低表达患者术后3年生存率(88.24%,45/51)高于LncRNA C5orf66-AS1高表达患者(69.64%,39/56),LncRNA SOX2-OT低表达患者术后3年生存率(92.45%,49/53)高于LncRNA SOX2-OT高表达患者(64.81%,35/54),差异有统计学意义(P<0.05).多因素Cox回归分析显示,TNM 分期为Ⅲ期、有淋巴结转移、LncRNA C5orf66-AS1、LncRNA SOX2-OT表达水平升高是乳腺癌患者术后3年死亡的危险因素(P<0.05).结论 乳腺癌组织中LncRNA C5orf66-AS1及LncRNA SOX2-OT表达水平明显升高,其与患者的临床病理特征及预后密切相关.
Objective To analyze the expressions of long non-codingRNA(LncRNA)C5orf66-AS1 and LncRNA SOX2-OT in breast cancer tissues,and to investigate their relationships with the clinicopathological characteristics and prognosis.Methods A total of 107 breast cancer patients who underwent modified radical mastectomy in the hospital from August 2020 to April 2022 were selected as the study subjects,breast cancer tissue and adjacent tissue samples resected during surgery were collected.RT-qPCR was used to detect the ex-pression levels of LncRNA C5orf66-AS1 and LncRNA SOX2-OT in cancer tissues and adjacent tissues.The relationship between the expression levels of LncRNA C5orf66-AS1 and LncRNA SOX2-OT and the patholog-ical characteristics of patients was analyzed.The Kaplan-Meier method was used to analyze the relationship between the expression levels of LncRNA C5orf66-AS1 and LncRNA SOX2-OT and the postoperative survival rate of patients.Univariate and multivariate Cox regression analyses were conducted to investigate the influen-cing factors of 3-year postoperative mortality in breast cancer patients.Results Compared with adjacent tis-sues,the expression levels of LncRNA C5orf66-AS1 and LncRNA SOX2-OT were elevated in breast cancer tissues(P<0.05).The expression levels of LncRNA C5orf66-AS1 and LncRNA SOX2-OT in breast cancer tissues were associated with the patient's TNM stage,degree of differentiation,and the presence of lymph node metastasis(P<0.05).The 3-year postoperative survival rate of patients with low expression of Ln-cRNA C5orf66-AS1 in breast cancer tissues(88.24%,45/51)was higher than that of patients with high ex-pression of LncRNA C5orf66-AS1(69.64%,39/56).The 3-year postoperative survival rate of patients with low expression of LncRNA SOX2-OT(92.45%,49/53)was higher than that of patients with high expression of LncRNA SOX2-OT(64.81%,35/54),the difference was statistically significant(P<0.05).Multivariate Cox regression analysis showed that TNM stage Ⅲ,the presence of lymph node metastasis,and elevated ex-pression levels of LncRNA C5orf66-AS1 and LncRNA SOX2-OT were risk factors for 3-year mortality in breast cancer patients(P<0.05).Conclusion The expression levels of LncRNA C5orf66-AS1 and LncRNA SOX2-OT are significantly elevated in breast cancer tissues,which are closely associated with the clinicopatho-logical characteristics and prognosis of the patients.
沈方媛;朱双九;朱元超;郑新闻;邵华
连云港市第二人民医院甲乳外科,江苏 连云港 222000连云港市第二人民医院甲乳外科,江苏 连云港 222000连云港市第二人民医院甲乳外科,江苏 连云港 222000连云港市第二人民医院甲乳外科,江苏 连云港 222000连云港市第二人民医院甲乳外科,江苏 连云港 222000
医药卫生
乳腺癌临床病理特征预后LncRNA C5orf66-AS1LncRNA SOX2-OT
breast cancerclinicopathological featuresprognosisLncRNA C5orf66-AS1LncRNA SOX2-OT
《重庆医学》 2026 (5)
997-1002,1009,7
江苏省连云港市卫生科技项目面上课题(202020).
评论